The government has proposed bringing several alcohol-based medicinal products under Schedule H1. The move aims to prevent misuse while ensuring patients continue to access genuine treatment.
India's Drug Deal Reform is set to tighten the country's public drug procurement system. The move aims to stop companies with canceled manufacturing licenses from securing government contracts. Officials believe the Drug Deal Reform will close...
Godavari Biorefineries has achieved a milestone in the global battle against cancer with the Japanese patenting of its anti-cancer molecule
Dr. Reddy's API issue is now impacting more than just the company's own semaglutide plans. In the latest development, Torrent Pharma recall has been announced for select batches of Semalix injection after Dr. Reddy's Laboratories informed the...
The Central Drugs Standard Control Organization (CDSCO) is tightening its focus on patient safety, which includes renewed efforts to eliminate irrational drug combinations
Indian institutes and regulatory bodies are effectively taking steps in dengue preparedness and medical solutions for the issue
India's medical device industry is on track for a major transformation. A new report by Bain & Company says the sector could unlock a USD 35 billion opportunity by 2030, making it one of the fastest-growing segments of India's healthcare ecosystem.
The Dr. Reddy's semaglutide delay has raised questions about the company's plans in one of the fastest-growing drug markets.
India is set to become one of the earliest markets for Novo Nordisk's breakthrough once-weekly insulin,The Danish drug maker is preparing to launch Awiqli after securing regulatory approval.
Wegovy is making a strong comeback in India's fast-growing weight loss drug market as generic weight loss drugs begin to lose momentum.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")